The CONNECT project aims to develop a novel organoid-chip connecting the blood vasculature to the brain to mimic the blood-brain barrier (BBB). This complex 3D-model can be used to mimic aspects of drug delivery into the human brain, a key process that is often not...
The TRANSCEND project aims to tackle the current limitations of drug development for Parkinson’s Disease by the integration of an innovative in vitro brain organoid model and a humanized in vivo mouse model. This unique two-step platform supports InnoSer’s aspiration...
Innovation is not only part of InnoSer’s name but is central to its activities. We believe, the solution for the continuously high drug attrition rates resides in addressing the problem already at the preclinical stages of drug development. More specifically, we aim...
Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. InnoSer has recently finished a project with promising results in understanding altered...
To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...